Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum DocuSign Inc DOCU

DocuSign, Inc. offers electronic signature product, enabling an agreement to be signed electronically on a variety of devices, from virtually anywhere in the world. The Company offers DocuSign Agreement Cloud, which is a cloud software platform that automates and connects the entire agreement process. It includes DocuSign eSignature, an electronic signature solution. It offers applications for... see more

Bullboard (NDAQ:DOCU)

View:
Post by Melany4on Apr 13, 2023 3:51am

Kevin Harrington Discusses FSD Pharma

I believe this new product will aid society in reducing the ...more  

Datametrex AI Launches AnalyticsGPT

The underlying AnalyticsGPT technology was developed in conjunction with and used by the U.S. and Canadian Military for defense initiatives and is characterized by its robustness, reliability, and precision. In the following weeks, Datametrex will be announcing additional packages and pricing models designed to allow smaller businesses to leverage the power of ...read more
Post by Melany4on Jun 03, 2022 5:10am

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Pharma ready to proceed with Phase 2 clinical trial of ...more  
Post by Melany4on Apr 18, 2022 2:23am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings ...more  

Thematica Insights Report and Investor Guide

Thematica: Battery Metals Report

Download our Investor’s Guide and learn how/why Battery Metals are playing a vital role in the EV Revolution.
Post by Melany4on Apr 09, 2022 3:11am

FSD: Cancellation of Certain Shares Issued to Former CEO

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ...more  
Post by Melany4on Apr 07, 2022 12:25pm

FSD Pharma Issues Corporate Updates

FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to ...more  
Post by Melany4on Apr 06, 2022 1:48am

iMining: First Hospital Foundation in Decentraland Metaverse

iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse   Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc ...more  
User Avatar Image
(24)
•••
  • Snowball1843657X
Post by Snowball1843657on Mar 12, 2022 12:23pm

Good investment?

Can somebody tell me why MSFT does not come up with same business model and put these guys out of business?
Post by Melany4on Feb 04, 2022 10:49am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid ...more  
Post by Melany4on Jan 01, 2022 12:50am

FSD Pharma Announces Share Repurchase Program

FSD Pharma Announces Share Repurchase Program   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >